1240253-00-2

Upstream product

• 208121-80-6 2-(4-fluorobenzoylamino)-2-methylpropionic acid 
• 1240253-07-9 3-amino-7-fluoro-1-methyl-5-[4-(trifluoromethoxy)benzyl]-1,3-dihydro-2H-1,4-benzodiazepin-2-one 

Downstream Products

• 1240253-08-0 4-fluoro-N-[2-(((S)-7-fluoro-1-methyl-2-oxo-5-(4-(trifluoromethoxy)benzyl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)amino)-1,1-dimethyl-2-oxoethyl]benzamide 
• 1240253-09-1 4-fluoro-N-[2-(((R)-7-fluoro-1-methyl-2-oxo-5-(4-(trifluoromethoxy)benzyl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)amino)-1,1-dimethyl-2-oxoethyl]benzamide 

Relevant academic research and scientific papers

1,4-BENZODIAZEPIN-2-ON DERIVATIVES

The present invention relates to a compound represented by a formula (I): wherein R1 represents a halogen atom or the like; R2 represents a hydrogen atom or the like; R3 and R4 each independently represents lower alkyl; R5 represents phenyl or the like; R6 represents a halogen atom or the like; m is an integer of from 0 to 2; p is an integer of from 1 to 4; and q is an integer of from 1 to 5 as an inhibitor of DGAT1 and its use for the treatment of hyperlipidemia etc.